Bin Lü

2.3k total citations
66 papers, 1.8k citations indexed

About

Bin Lü is a scholar working on Molecular Biology, Ophthalmology and Epidemiology. According to data from OpenAlex, Bin Lü has authored 66 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Ophthalmology and 13 papers in Epidemiology. Recurrent topics in Bin Lü's work include Retinal Diseases and Treatments (15 papers), Liver Disease Diagnosis and Treatment (12 papers) and Glaucoma and retinal disorders (8 papers). Bin Lü is often cited by papers focused on Retinal Diseases and Treatments (15 papers), Liver Disease Diagnosis and Treatment (12 papers) and Glaucoma and retinal disorders (8 papers). Bin Lü collaborates with scholars based in China, United States and Australia. Bin Lü's co-authors include Lili Ji, Zhengtao Wang, Yuchen Sheng, Xiyu Mei, Tianyu Zhang, Zengyang Yu, Hao Ouyang, Liang Shi, Mengjuan Wei and Zhenlin Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Bin Lü

64 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bin Lü China 28 757 305 297 269 263 66 1.8k
Mohammed M.H. Al-Gayyar Egypt 32 879 1.2× 192 0.6× 188 0.6× 197 0.7× 208 0.8× 94 2.4k
Junghyun Kim South Korea 29 809 1.1× 277 0.9× 207 0.7× 173 0.6× 161 0.6× 127 2.6k
Lingpeng Zhu China 27 1.4k 1.9× 334 1.1× 328 1.1× 171 0.6× 234 0.9× 46 2.5k
Fang Huang China 28 1.2k 1.5× 304 1.0× 280 0.9× 383 1.4× 284 1.1× 98 2.6k
Yuchen Sheng China 25 776 1.0× 217 0.7× 604 2.0× 267 1.0× 193 0.7× 46 1.7k
Chan‐Sik Kim South Korea 29 673 0.9× 202 0.7× 154 0.5× 102 0.4× 136 0.5× 98 2.3k
Xing Lin China 25 603 0.8× 137 0.4× 336 1.1× 486 1.8× 128 0.5× 76 1.8k
Tom Huang Australia 23 1.2k 1.6× 258 0.8× 288 1.0× 232 0.9× 245 0.9× 43 2.4k
Hyo Won Jung South Korea 27 718 0.9× 188 0.6× 280 0.9× 142 0.5× 356 1.4× 83 1.8k
Shinjiro Kobayashi Japan 20 590 0.8× 181 0.6× 174 0.6× 87 0.3× 134 0.5× 68 1.2k

Countries citing papers authored by Bin Lü

Since Specialization
Citations

This map shows the geographic impact of Bin Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Lü more than expected).

Fields of papers citing papers by Bin Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bin Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Lü. The network helps show where Bin Lü may publish in the future.

Co-authorship network of co-authors of Bin Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Bin Lü. A scholar is included among the top collaborators of Bin Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bin Lü. Bin Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Yuan, et al.. (2025). Biosafety and Efficacy Studies of Colchicine‐Encapsulated Liposomes for Ocular Inflammatory Diseases. Journal of Biomedical Materials Research Part B Applied Biomaterials. 113(2). e35540–e35540. 1 indexed citations
2.
Ouyang, Hao, Ao Du, Shiyuan Dong, et al.. (2024). Chlorogenic acid ameliorates non-proliferative diabetic retinopathy via alleviating retinal inflammation through targeting TNFR1 in retinal endothelial cells. International Immunopharmacology. 141. 112929–112929. 5 indexed citations
5.
Zhang, Jingnan, Ze Zhang, Zhenlin Huang, et al.. (2023). Isotoosendanin exerts inhibition on triple-negative breast cancer through abrogating TGF-β-induced epithelial–mesenchymal transition via directly targeting TGFβR1. Acta Pharmaceutica Sinica B. 13(7). 2990–3007. 20 indexed citations
6.
Wei, Mengjuan, Tianyu Zhang, Hao Ouyang, et al.. (2023). Erianin alleviated liver steatosis by enhancing Nrf2-mediated VE-cadherin expression in vascular endothelium. European Journal of Pharmacology. 950. 175744–175744. 3 indexed citations
7.
Zhang, Shaobo, Ao Du, Hui Miao, et al.. (2021). Network pharmacology-based identification of significant pathway for protection of Yinhuang granule in a mice model of metabolic-associated fatty liver disease. Phytomedicine. 91. 153666–153666. 6 indexed citations
8.
Zhao, Qing, Mengjuan Wei, Shaobo Zhang, et al.. (2020). The water extract of Sophorae tonkinensis Radix et Rhizoma alleviates non-alcoholic fatty liver disease and its mechanism. Phytomedicine. 77. 153270–153270. 14 indexed citations
9.
Shi, Liang, Zhenlin Huang, Bin Lü, et al.. (2020). Identification of photodegraded derivatives of usnic acid with improved toxicity profile and UVA/UVB protection in normal human L02 hepatocytes and epidermal melanocytes. Journal of Photochemistry and Photobiology B Biology. 205. 111814–111814. 9 indexed citations
10.
Shi, Liang, Shaobo Zhang, Mengjuan Wei, et al.. (2018). Baicalein and baicalin alleviate acetaminophen-induced liver injury by activating Nrf2 antioxidative pathway: The involvement of ERK1/2 and PKC. Biochemical Pharmacology. 150. 9–23. 120 indexed citations
11.
Mei, Xiyu, et al.. (2017). Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis. Vascular Pharmacology. 101. 29–37. 57 indexed citations
12.
Shi, Liang, Guoqing Zhang, Zhiyong Zheng, Bin Lü, & Lili Ji. (2017). Andrographolide reduced VEGFA expression in hepatoma cancer cells by inactivating HIF-1α: The involvement of JNK and MTA1/HDCA. Chemico-Biological Interactions. 273. 228–236. 38 indexed citations
13.
Yu, Zengyang, Bin Lü, & Chenyuan Gong. (2016). Streptozotocin induced diabetic retinopathy in C57 mice and the expression of some pro-angiogenic molecules. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Zhao, Hongwei, Chen Wang, Bin Lü, et al.. (2016). Pristimerin triggers AIF-dependent programmed necrosis in glioma cells via activation of JNK. Cancer Letters. 374(1). 136–148. 48 indexed citations
15.
Zhang, Tianyu, et al.. (2016). Lonicerae Japonicae Flos attenuates diabetic retinopathy by inhibiting retinal angiogenesis. Journal of Ethnopharmacology. 189. 117–125. 34 indexed citations
16.
Yu, Zengyang, et al.. (2015). Andrographolide ameliorates diabetic retinopathy by inhibiting retinal angiogenesis and inflammation. Biochimica et Biophysica Acta (BBA) - General Subjects. 1850(4). 824–831. 62 indexed citations
17.
Ji, Lili, et al.. (2015). Andrographolide decreased VEGFD expression in hepatoma cancer cells by inducing ubiquitin/proteasome-mediated cFos protein degradation. Biochimica et Biophysica Acta (BBA) - General Subjects. 1850(4). 750–758. 21 indexed citations
18.
Shen, Kaikai, Lili Ji, Bin Lü, et al.. (2014). Andrographolide inhibits tumor angiogenesis via blocking VEGFA/VEGFR2-MAPKs signaling cascade. Chemico-Biological Interactions. 218. 99–106. 44 indexed citations
19.
Gong, Chenyuan, Zengyang Yu, Bin Lü, et al.. (2014). Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism. Vascular Pharmacology. 62(3). 134–142. 43 indexed citations
20.
Zhang, Jiaqi, et al.. (2014). Therapeutic detoxification of quercetin against carbon tetrachloride-induced acute liver injury in mice and its mechanism. Journal of Zhejiang University SCIENCE B. 15(12). 1039–1047. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026